2023年6月28日,

信貸:Pexels位於電暈的補救措施,重要的私人股本公司ChrysCapital作為投資者,購買了製藥企業賽諾菲安萬特醫療印度的肌肉鬆弛劑品牌Myoril 234盧比。這筆交易之際,賽諾菲安萬特是使分解其消費者保健業務全資附屬公司,賽諾菲安萬特印度消費者保健。Myoril品牌的收購印度市場是有效的從6月28日,2023年。該協議旨在位置電暈肌肉鬆弛劑段的關鍵球員,一個新聞聲明中說。廣告Myoril肌肉鬆弛劑是一個流行的品牌空間38盧比的收入。該協議旨在加強電暈的超過80個品牌現有的陣容。ChrysCapital在2021年收購了27%的股份電暈療法通過二次交易。這筆交易幫助私人股本公司Creador電暈出售其全部的股份。電暈補救措施,2004年由Kirtibhai梅塔和他的兒子Nirav梅塔和Ankur梅赫塔生產藥片、膠囊、糖漿、藥膏、油漆、膠和注射劑。印度各地廣告電暈補救措施擴大了它的存在,也進入了新的治療領域通過結合有機和無機增長路線。 In 2017, VCCircle reported that Corona Remedies would buy portfolio of drugs from a multinational pharmaceuticals company to scale up its business. It also acquired a minority stake in hormone active pharmaceutical ingredient (API) maker La Chandra Pharmalab. Sanofi India reported a decline of 20.1% in net profit to Rs 190.4 crore against Rs 238.4 crore y-o-y. Revenue from operations rose by 4.2% to Rs 736.5 crore in the quarter under review from Rs 707 crore in the year ago period, said Sanofi India in its regulatory filing. Advertisement The consumer healthcare business of the company includes assets, liabilities and all other aspects pertaining to the consumer healthcare business including brands like Allegra, Combiflam, DePURA , Avil, and others.